<DOC>
	<DOCNO>NCT03093051</DOCNO>
	<brief_summary>This observation study evaluate safety effectiveness UPT therapy subject either indicated ventricular tachycardia ablation procedure ICD implant procedure .</brief_summary>
	<brief_title>Termination Therapy Ventricular Tachyarrhythmias</brief_title>
	<detailed_description>This non-blinded , single-arm open-label , non-significant risk , phase 1 pilot , acute research feasibility trial aim demonstrate safety effectiveness Unpinning Termination ( UPT ) electrotherapy observe canine translate human demonstrate safety effectiveness UPT electrotherapy human population likely benefit therapy . This observation study evaluate safety effectiveness UPT therapy subject either indicated ventricular tachycardia ( VT ) catheter ablation indicate initial implant device replacement implantable cardioverter defibrillator ( ICD ) .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>1 . Life expectancy 1 year great 2 . Male female 18 75 year age 3 . Willingness ability comply study protocol , include provide write , inform consent 4 . Subject indicated cardiac catheter ablation procedure sustain VT/VF nonsustained VT associate electrophysiology study OR subject indicate implantable cardioverter defibrillator implant replacement , time study consent , medically stable undergo defibrillation safety margin test procedure perform conscious sedation determine investigator The subject must meet follow exclusion criterion : 1 . Medically unstable time study undergo defibrillation test 2 . Hemodynamic instability determine investigator 3 . Prior VT ablation history hemodynamic compromise 4 . Atrial Tachyarrhythmia ( AT/AFl/AF ) time study procedure 5 . Incessant VT/VF 6 . Inability Tolerate Systemic Anticoagulation 7 . LVEF &lt; 15 % 8 . New York Heart Association ( NYHA ) Class IV 9 . History intracardiac thrombus 10 . History hypercoagulable state increase risk thrombus 11 . History hemodynamic compromise severe aortic stenosis 12 . Inability Pass Catheters Heart Due Vascular Limitations 13 . Cardiovascular anatomical defect would complicate placement lead catheter require protocol , include congenital heart disease cardiac vein anomaly determine investigator 14 . Unstable CAD determine investigator 15 . Severe proximal threevessel leave main coronary artery disease without revascularization determine investigator 16 . History embolic stroke , Transient Ischemic Attack thromboembolic event 17 . History Hypertrophic Cardiomyopathy , Arrhythmogenic RV Dysplasia 18 . Cardiovascular surgery intervention within 1 month prior enrollment plan 1 month enrollment ( plan treatment procedure ) 19 . Pregnancy confirm test within 7 day procedure 20 . Pacemaker Dependency 21 . Morbid obesity : BMI &gt; 39 kg/m2 22 . Medically unstable time study undergo defibrillation test 23 . Cognitive mental health status would interfere study participation proper informed consent 24 . Presence permanently implant medical device ( e.g . artificial cardiac valve ) may affect outcome study safety subject , determine investigator ( except ICD ) 25 . History significant Peripheral Vascular Disease , include peripheral vascular intervention IVC filter placement 26 . Any medical condition may affect outcome study safety subject determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Termination</keyword>
	<keyword>Unpinning</keyword>
	<keyword>Therapy</keyword>
</DOC>